Tirzepatide × Peptuvia — supplier's lab test, September 2026
COA 228781 matches Janoshik Labs's public record. So this test doesn't rest on our review alone — the lab confirms it too.
The portal confirms the certificate. It can't show that a vial you buy from Peptuvia is from this batch — compare the lot on yours.
5MAX1GKY61I1Test results
This is a purity and identity analysis. Sterility, endotoxins, and heavy metals were not screened — a high purity figure says nothing about those.
About this test
Label 30 mg · Lab measured 33.46 mg
112% of label, basis not stated — shown as printed. Reconstituted with 2 mL, a 50-unit draw holds 8.4 mg using the measured mass, against 7.5 mg on the label — 12% more.
One vial from this lot was weighed by the laboratory, not yours. This page reports what the certificate says; it does not recommend a dose.
| Report number | 228781 |
|---|---|
| Portal lookup | ✓ Lab-verified |
| PDF vs portal | Janoshik Labs's portal shows validity only |
| Weight | Listed for information — supplier-provided, not counted |
HPLC purity analysis of Tirzepatide sold by Peptuvia, ordered by its supplier and performed by Janoshik Labs on September 8, 2026. Reported purity: 99.765%. Net content: 33.46 mg against 30 mg labeled (112% of label). Tested content exceeds the labeled amount by 12%. Batch PGB-T30-4. Sample source: supplier-provided. Certificate of analysis attached.
Certificate of analysis
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.
Community discussion